SecBot SecBot
8-K ·Filed Apr 29, 2026

ASRT

Assertio Holdings, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001104659-26-051692
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor for competing bids during the window-shop period; if no superior proposal emerges by May 4, the tender offer is expected to commence. Stock likely trades near the $18 offer price with deal spread reflecting timing risk.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ASRT ▲ +27.18% at T+20d
NEUTRAL call +27.18% · α vs SPY +21.96% · entry $18.43 → $23.44
Next anchor: T+60d due 3mo ago
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
+0.22%
call +0.22% · α -0.00%
$18.47
settled 6mo ago
T+5d
+21.38%
call +21.38% · α +19.65%
$22.37
settled 6mo ago
T+20d
+27.18%
call +27.18% · α +21.96%
$23.44
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Assertio Holdings and Garda Therapeutics mutually agreed to extend the deadline to commence the tender offer to purchase all outstanding Assertio shares to May 4, 2026. The original deal terms of $18.00 per share cash ($125.1 million total) plus a contingent value right remain unchanged. The window-shop period allowing Assertio to seek superior proposals remains active.

Key Facts

  • Tender offer commencement deadline extended to May 4, 2026
  • Original offer: $18.00 per share cash, total $125.1 million plus contingent value right
  • 20-day window-shop period remains in effect through at least April 28, 2026
  • Reduced breakup fee applies if board accepts superior bid during window-shop period

Financial Impact

No financial data in filing; deal value unchanged at $125.1 million

Risk Factors

  • Deal may fail if Garda cannot secure financing or if antitrust/regulatory hurdles arise
  • Competing bid could disrupt the transaction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-051692
Document: tm2611405d14_ex99-1.htm0001104659-26-051692
Document: 0001104659-26-051692-index-headers.html0001104659-26-051692
Document: 0001104659-26-051692-index.html0001104659-26-051692
Document: 0001104659-26-051692.txt0001104659-26-051692
10 reports for ASRT
Performance horizon
100% Hit rate @ T+20 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+20▲ +23.20%Apr 9, 2026
Filters
Rows
Reports for ASRT — sortable, filterable
TypeNow
Jul 7, 2026
16w ago
25-NSE
NEUTRAL ★ 5/10
—awaiting T+20——
Jun 26, 2026
17w ago
15-12G
NEUTRAL ★ 6/10
$23.50awaiting T+20——
Jun 18, 2026
18w ago
EFFECT
NEUTRAL ★ 5/10
$23.50awaiting T+20——
Jun 16, 2026
19w ago
8-K
BULLISH ★ 7/10
$23.50awaiting T+20——
May 18, 2026
23w ago
8-K
BULLISH ★ 8/10
$23.32 $23.50▲ +0.77%▼ −0.81%—
May 8, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$22.50 $23.44▲ +4.18%▲ +4.15%—
May 5, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$22.16 $23.45▲ +5.82%▲ +0.87%—
May 4, 2026
25w ago
8-K
BULLISH ★ 8/10
$21.61 $23.43▲ +8.42%▲ +2.78%—
Apr 29, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$18.43 $23.44▲ +27.18%▲ +21.96%—
Apr 9, 2026
28w ago
8-K
BULLISH ★ 8/10
$18.02 $22.20▲ +23.20%▲ +15.63%—
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026